Have anyone read goldman sach recommendation on tassal and huon put out on 4th Dec 2017? Upgraded TP and put into ANZ conviction list. TGR $4.60 and HUO $6.05.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025